The National Institutes of Health’s response to infection control issues at a specialized pharmacy in its hospital in Bethesda, Md., has put clinical trials in jeopardy and patients on the backburner, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback